For patients with obesity-related complications, ongoing treatment helps manage these conditions alongside weight management
The same study also found that: 90.7% of people lose at least 5% of their starting weight 82.4% of people lose at least 10% of their starting weight 66.5% of people lose at least 15% of their starting weight 47.7% of people lose at least 20% of their starting weight 31.2% of people lose at least 25% of their starting weight On the Wegovy tablet, clinical trials have found that people lose an average 17% of their starting weight
ElSayed N.A., Aleppo G., Bannuru R.R., Bruemmer D., Collins B.S., Ekhlaspour L., Gaglia J.L., Hilliard M.E., Johnson E.L., et al
In overt hypothyroidism, especially with concurrent dyslipidemia, levothyroxine therapy has been shown to improve hepatic lipid metabolism and reduce MASLD severity
* Correspondence: Nadia Akawi [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
